Additionally, GPRC5A, whose expression is induced by phorbol ester and retinoic acid (58), disrupts the Hippo pathway by modulating YAP transcription through the cAMP-CREB axis, demonstrating the diversity of the GPCR-mediated regulation of YAP/TAZ in cancer progression (59). The gene discussed is YAP1; the disease is cancer.